Sinohealth Holdings Limited (HKG:2361)

Sinohealth Holdings Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	403.73	396.19	356.67	324.17	202.07
Revenue Growth (YoY)	1.90%	11.08%	10.03%	60.42%	13.68%
Cost of Revenue	170.53	172.72	197.56	131.53	71.87
Gross Profit	233.2	223.47	159.11	192.64	130.21
Selling, General & Admin	78.58	67.05	77.77	68.95	31.31
Research & Development	64.77	61.09	60.41	53.71	39.82
Other Operating Expenses	-	-	-	0.02	0.11
Operating Expenses	152.69	145.75	140.86	125.19	71.93
Operating Income	80.51	77.72	18.25	67.45	58.28
Interest Expense	-0.62	-0.64	-0.41	-0.53	-1.22
Interest & Investment Income	26.88	27.17	15.11	6.97	12.46
Earnings From Equity Investments	-	-	-	-0.42	-
Currency Exchange Gain (Loss)	4.86	2.29	9.53	0.04	0
Other Non Operating Income (Expenses)	8.46	4.19	11.44	16.1	3.51
EBT Excluding Unusual Items	120.09	110.73	53.92	89.61	73.03
Gain (Loss) on Sale of Investments	-	-	0.04	4.82	2.99
Gain (Loss) on Sale of Assets	-	-	0.52	-	0.04
Other Unusual Items	0.06	0.01	-	1.11	0.01
Pretax Income	120.15	110.74	54.47	95.53	76.07
Income Tax Expense	8.33	9.8	0.26	23.55	10.74
Earnings From Continuing Operations	111.82	100.94	54.21	71.98	65.33
Minority Interest in Earnings	-1.17	1.09	1.55	6.84	2.6
Net Income	110.65	102.03	55.76	78.81	67.93
Net Income to Common	110.65	102.03	55.76	78.81	67.93
Net Income Growth	8.45%	82.99%	-29.25%	16.03%	21.10%
Shares Outstanding (Basic)	410	426	411	373	-
Shares Outstanding (Diluted)	410	426	411	373	-
Shares Change (YoY)	-3.74%	3.76%	10.06%	-	-
EPS (Basic)	0.27	0.24	0.14	0.21	-
EPS (Diluted)	0.27	0.24	0.14	0.21	-
EPS Growth	12.65%	76.35%	-35.72%	-	-
Free Cash Flow	89.43	75.94	29.78	58.14	60.67
Free Cash Flow Per Share	0.22	0.18	0.07	0.16	-
Dividend Per Share	0.113	0.066	0.035	-	-
Dividend Growth	71.35%	86.93%	-	-	-
Gross Margin	57.76%	56.41%	44.61%	59.43%	64.44%
Operating Margin	19.94%	19.62%	5.12%	20.81%	28.84%
Profit Margin	27.41%	25.75%	15.63%	24.31%	33.62%
Free Cash Flow Margin	22.15%	19.17%	8.35%	17.94%	30.02%
EBITDA	83.15	80.15	20.91	69.53	60.21
EBITDA Margin	20.59%	20.23%	5.86%	21.45%	29.80%
D&A For EBITDA	2.64	2.43	2.66	2.08	1.93
EBIT	80.51	77.72	18.25	67.45	58.28
EBIT Margin	19.94%	19.62%	5.12%	20.81%	28.84%
Effective Tax Rate	6.93%	8.85%	0.48%	24.65%	14.12%

Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.